1Battegay E J. Angiogenesis: mechanistic insights, nevascular diseases and therapeutic prospects.J Mol med, 1995 ,73(7):333-346. 被引量：1
2Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med,1971,285(21): 1182-1186. 被引量：1
3Folkman J. Clinical applications of research on angiogenesis. N Engl J Med,1995,333(26): 1757-1763. 被引量：1
4Folkman J. Tumor angiogenesis. In: Holland J F, et al eds. Cancer Medicine,4 thed, vol. 1. Baltimore:The Williams & Wilkins Co, 1997, 181-204. 被引量：1
5Keller G, Lacaud D Robertson S Development of the hematopoietic system in the mouse. Exp Hematol, 1999,27 (5): 777-787. 被引量：1
6Li H, Lu H, Criscelli-Fet al. Adenovirus mediated delivery of a uPA/uPAR antagonist suppressed angiogenesis-dependent tumor growth and dissemination in mice. Gene Ther, 1998,5(8): 1105-1113. 被引量：1
7Brooks P C,Clark RA,Cheresh D A. Requirement of vascular integrin αvβ3for angiogenesis. Science, 1994,264 ( 5158): 569-571. 被引量：1
8Yancopoulos G D, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis,and growth factors:ephrins enter the fray at the border. Cell, 1998,93(5):661-664. 被引量：1
9Isner J M, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest, 1999, 103(9):1231-1236. 被引量：1
10Holash J,Maisonpierre PC, Compton D, et al. Vessel cooption, regression,and growth in tumors mediated by angiopoietin and VEGF. Science, 1999,284( 5422): 1994-1998. 被引量：1
二级参考文献20
1[1]Kerbel RS. Tumor angiogenesis: past, present and near future [J]. Carcinogenesis, 2000,21(3):505-515. 被引量：1
2[2]Edinger M, Sweeney TJ, Tucker AA, et al. Noninvasive assessment of tumor cell proliferation in animal models [J]. Neoplasia, 1999,1(4):303-310. 被引量：1
3[3]Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice [J]. Cancer Metastasis Rev, 1998-1999,17(3):279-284. 被引量：1
4[4]Bergers G, Javaherian K, Lo KM, et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J]. Science, 1999,284(5415):808-812. 被引量：1
5[5]Sledge GW Jr, Miller KD. Angiogenesis and antiangiogenic therapy [J]. Curr Probl Cancer, 2002,26(1):1-60. 被引量：1
6[6]Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation [J]. Pharmacological Reviews, 2000,52(2):237-268. 被引量：1
7[7]Folkman J, Browder T, Palmblad J. Angiogenesis Research: Guidelines fot Translation to Clinical Application [J]. Thromb Haemost, 2001,86(1):23-33. 被引量：1
8[8]Wu JT. Review of circulating tumor markers: from enzyme, carcinoembryonic protein to oncogene and suppressor gene [J]. Ann Clin Lab Sci, 1999,29(2):106-111. 被引量：1
9[9]Pham CD, Roberts TP, van Bruggen N, et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after adiministration of antibody to vascular endothelial growth factor [J]. Cancer Invest, 1998,16(4):225-230. 被引量：1
10[10]Yokoyama Y, Dhanabal M, Griffioen AW, et al. Synergy between angiostatin and endostatin: Inhibition of varian cancer growth [J]. Cancer Res, 2000,60(8):2190-2196. 被引量：1
